Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia
Study Details
Study Description
Brief Summary
Descriptive prospective study to investigate the prevalence of COVID 19 during ambulant screening
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
The exact prevalence of COVID-19 is unknown. Due to the relatively high number of diagnosed, symptomatic infections despite a strict policy, we expect a high prevalence of COVID 19 throughout the entire population. The risk that an asymptomatic carrier who is admitted to the hospital for a (semi)urgent surgery, treatment of investigation transfers the virus to the hospital staff is very high, and vice versa. This risk is even higher during surgery, where intubation is necessary. Therefore we would like to pre-screen all patients ambulantly on the presence of COVID 19 since there is no consensus for screening at the moment. The golden standard is the SARS CoV-2 PCR on the nasopharyngeal sample together with a CT scan of the lungs. Patients in which a bloodsample is taken as standard of care procedure in this ambulant screening will be asked to give more blood for further investigation.
On top of this standard of care screening, we will perform a questionnaire at the pre-operative visit which evaluates the possible occurence of certain symptoms in the last 2 weeks. These symptoms are fever, anorexia, cough, diarrhea, sneezing, vomiting, dyspnea, headache, rhinorrhea, loss of smell, muscle pain, sputum, sore throat and fatigue. Patients were also asked if one of their housemates are affected by these symptoms. Furthermore, 2 weeks after surgery, patient will be contacted to phone in order to fill the same questionnaire.
Study Design
Outcome Measures
Primary Outcome Measures
- Prevalence of symptoms [at the ambulant screening]
Prevalence of fever, cough, anorexia, fatigue, diarrhea, vomiting, dyspnee, sore throat and sputum
- Prevalence of positive Sars CoV-2 PCR [at the ambulant screening]
Prevalence of positive COVID 19 tests in patients planned for surgery, treatment or investigation in the hospital
- Prevalence of positive radiological findings [at the ambulant screening]
Prevalence of positive radiological findings in CT scans of the lungs of planned for surgery, treatment or investigation in the hospital
Secondary Outcome Measures
- Prediction of symptoms [2 weeks after surgery or treatment]
Prediction of symptoms of COVID 19, based on evaluated baseline questionnaire
- Prediction of symptoms [2 weeks after surgery or treatment]
Prediction of symptoms of COVID 19, based on radiological findings of CT scans
- Prediction of symptoms [2 weeks after surgery or treatment]
Prediction of symptoms of COVID 19, based on COVID 19 PCR results
Eligibility Criteria
Criteria
Inclusion Criteria:
- All adult patients > 18 years scheduled for a (semi) urgent surgery, hematological or oncological treatment or elektrophysiciological investigations in the Jessa hospital
Exclusion Criteria:
-
Patients < 18 years
-
Adult patients who are unable the give informed consent
-
Language barrier
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Jessa hospital | Hasselt | Belgium | 3500 |
Sponsors and Collaborators
- Jessa Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- JessaH_COVID19_prescreening